by EmpathiCSubstanceS | Apr 20, 2022 | Cancer, Iboga, Kambo, LSD, Parkinson's Disease, Psilocybin Magic Mushroom, Psychotropics, PTSD
Adults who have at some time in their life used psilocybin – a psychedelic substance produced by some types of mushrooms – are 30% less likely to have opioid use disorder, according to a nationally representative survey of US adults reported in the journal Scientific...
by EmpathiCSubstanceS | Apr 20, 2022 | Cancer, Neuropathy, NN-Dimethyltryptamine, OCD, Pain, Parkinson's Disease, Psilocybin Magic Mushroom, Psychotropics, PTSD, San Pedro Mescaline
Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the...
by EmpathiCSubstanceS | Apr 20, 2022 | Ayahuasca, Cancer, CBC, Iboga, Pain, Psilocybin Magic Mushroom, San Pedro Mescaline
Psilocybin, the psychedelic compound found in magic mushrooms, helps to “open up” depressed people’s brains, even after use, enabling brain regions to talk more freely to one another. These are the findings of a new analysis of brain scans from close to 60 people...
by EmpathiCSubstanceS | Feb 2, 2022 | Cancer, Cannabis Marijuana, CBC, Chronic Pain, Cluster Headaches, Depression, DMT, MDMA Sassafras Molly, OCD
From the late 1950s to the early 1970s a novel experimental paradigm was employed to use hallucinogenic drugs to address the existential anxiety, depression and demoralization often experienced by individuals suffering from terminal cancer. In spite of highly...
by EmpathiCSubstanceS | Jan 14, 2022 | Addiction, Alcoholism, Anxiety, Ayahuasca, Bipolar Disorder, Cancer, Cannabis Marijuana, CBC, Chronic Pain
Before you start a psychedelic venture or adventure, keep in mind that there are many psychedelic gimmicks that have long preceded the current “shroom boom.” As Alan Watts is purported to have said, “Anybody who tells you that he has some way of leading you to...
